Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT04716452 · RECRUITING

Trial details

NCT number: NCT04716452
Sponsor: Keystone Nano, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia, Refractory Refractory/Relapse Acute Myeloid Leukemia

Start date: 2025-10-01
Primary completion: 2026-09-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.